Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
UroShape is a private U.S. medical device company focused on chronic pelvic pain and related pelvic floor muscle spasm. The company develops and commercializes SoLá Pelvic Therapy, a proprietary class IV near-infrared photobiomodulation laser system delivered through a wand-based device for use by licensed professionals. Its technology is positioned as a non-drug treatment intended to reduce pain, improve circulation, and relieve muscle spasm in patients with chronic pelvic pain syndromes. UroShape appears to operate as a small commercial-stage medtech company rather than a traditional therapeutic biotech, with a limited product portfolio centered on its SoLá platform.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on UroShape.